Brooks Laboratories FY26 PAT jumps to Rs 24.55 crore; sells JV stake for Rs 106 crore

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Brooks Laboratories FY26 PAT jumps to Rs 24.55 crore; sells JV stake for Rs 106 crore

Brooks Laboratories reported a strong turnaround for FY26, with consolidated PAT at Rs 24.55 crore against a loss last year. The company also divested its stake in Brooks Steriscience Limited for Rs 106.33 crore.

Brooks Laboratories Reports Strong FY26 Turnaround, Sells JV Stake

Consolidated PAT ₹24.55 crore vs (₹9.99 crore); JV stake sale ₹106.33 crore. Reader Takeaway: Profit surge driven by JV profit share, while stake sale injects capital for growth.
Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.